Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004875 · ClinicalTrials.gov registry record
Heparin or Enoxaparin in Patients With Cancer
A clinical trial, sponsored by Northwestern University.
- Completed
- Registry status
- 6
- Enrollment target
NCT00004875 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 6 participants.
The verdict
NCT00004875 has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 6 participants
- Enrollment target
Study Summary
RATIONALE: Heparin or enoxaparin may be effective in preventing the formation of blood clots in patients with cancer who are undergoing surgery to remove the tumor. PURPOSE: Randomized clinical trial to compare the effectiveness of heparin with that of enoxaparin in patients who have cancer.
Interventions
- DRUG enoxaparin
- DRUG heparin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 1996-07 |
| Est. Completion | 1999-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00004875
The ClinicalTrials.gov registry entry for NCT00004875 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which enoxaparin is the first listed.
NCT00004875 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00004875 about?
NCT00004875 is a clinical study titled "Heparin or Enoxaparin in Patients With Cancer". RATIONALE: Heparin or enoxaparin may be effective in preventing the formation of blood clots in patients with cancer who are undergoing surgery to remove the tumor. PURPOSE: Randomized clinical trial to compare the effectiveness of heparin with that of enoxaparin in patients who have cancer.
What is the current status of trial NCT00004875?
This trial is currently completed. The enrollment target is 6 participants. The study started on 1996-07. Estimated completion is 1999-03.
What interventions are being tested in trial NCT00004875?
The interventions under investigation include: enoxaparin (DRUG), heparin (DRUG).
Who is sponsoring clinical trial NCT00004875?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.